Highlights from the hearings of the new EU Commissioners
by Giuliana Miglierini The hearings of the Commissioners-designate before the relevant committees of the European Parliament closed with…
Mario Draghi’s report, a focus on the proposed actions for the pharma sector
by Giuliana Miglierini The report on the Future of European competitiveness was presented by Mario Draghi on 17…
UK will participate to European research programmes
by Giuliana Miglierini The divergent road opened as a consequence of the Brexit, in January 2021, between the…
The debate on the “Do No Significant Harm” principle in R&D
by Giulianna Miglierini The “Do No Significant Harm” (DNSH) principle is a widely diffused approach aimed to guarantee…
European Council’s conclusions on the European Innovation Agenda and research infrastructures
by Giuliana Miglierini The European socio-economic framework is undergoing a profound transformative moment, as a result of the…
The new European Innovation Agenda
by Giuliana Miglierini A new piece of legislation adds to the framework supporting the new paradigms set forth…